Nitric oxide donor agents for the treatment of ischemia/reperfusion injury in human subjects: A systematic review

Shock

Volumn 39, Issue 3, 2013, Pages 229-239

  Roberts, Brian W ^a   Mitchell, Jessica ^a   Kilgannon, J Hope ^a   Chansky, Michael E ^a   Trzeciak, Stephen ^a  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

Author keywords

Ischemia; ischemia reperfusion injury; nitric oxide; nitrite; reperfusion; resuscitation

Indexed keywords

ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; DETAJMIUM BITARTRATE; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; LINSIDOMINE; METHEMOGLOBIN; MOLSIDOMINE; MYELOPEROXIDASE; NICORANDIL; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PADGEM PROTEIN; PENTAERYTHRITYL TETRANITRATE; POTASSIUM NITRATE;

ANTIINFLAMMATORY ACTIVITY; BRAIN ISCHEMIA; CARDIOPULMONARY BYPASS; CEREBROVASCULAR ACCIDENT; CINAHL; COCHRANE LIBRARY; COMPETITIVE INHIBITION; HEART ARREST; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; LIVER TRANSPLANTATION; LOW DRUG DOSE; LUNG TRANSPLANTATION; MEDLINE; QUALITATIVE ANALYSIS; REPERFUSION INJURY; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW;

CARDIOPULMONARY BYPASS; HUMANS; MYOCARDIAL INFARCTION; NITRIC OXIDE DONORS; ORGAN TRANSPLANTATION; REPERFUSION INJURY;

EID: 84874268778     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31827f565b     Document Type: Review

References (95)

1. Moncada S, Higgs EA: The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 147(Suppl 1):S193-S201, 2006.
2. Kietadisorn R, Juni RP, Moens AL: Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities. Am J Physiol Endocrinol Metab 302:E481YE495, 2012.
3. Hur GM, Ryu YS, Yun HY, Jeon BH, Kim YM, Seok JH, Lee JH: Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-kappaB. Biochem Biophys Res Commun 261:917-922, 1999.
4. Savoye G, Tamion F, Richard V, Varin R, Thuillez C: Hemorrhagic shock resuscitation affects early and selective mesenteric artery endothelial function through a free radicalYdependent mechanism. Shock 23:411-416, 2005.
5. North AJ, Lau KS, Brannon TS, Wu LC, Wells LB, German Z, Shaul PW: Oxygen upregulates nitric oxide synthase gene expression in ovine fetal pulmonary artery endothelial cells. Am J Physiol 270:L643-L649, 1996.
6. Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I: Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest 91:437-442, 1993.
7. Williams MW, Taft CS, Ramnauth S, Zhao ZQ, Vinten-Johansen J: Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc Res 30:79-86, 1995.
8. Hoshida S, Yamashita N, Igarashi J, Nishida M, Hori M, Kamada T, Kuzuya T, Tada M: Nitric oxide synthase protects the heart against ischemia-reperfusion injury in rabbits. J Pharmacol Exp Ther 274:413-418, 1995.
9. Pabla R, Buda AJ, Flynn DM, Blesse SA, Shin AM, Curtis MJ, Lefer DJ: Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res 78:65-72, 1996.
10. Burwell LS, Nadtochiy SM, Tompkins AJ, Young S, Brookes PS: Direct evidence for S-nitrosation of mitochondrial complex I. Biochem J 394:627-634, 2006.
11. Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, Burwell L, Wang X, MacArthur PH, Shoja A, Raghavachari N, et al.: Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 204:2089-2102, 2007.
12. Sun J, Steenbergen C, Murphy E: S-nitrosylation: NO-related redox signaling to protect against oxidative stress. Antioxid Redox Signal 8:1693-1705, 2006.
13. Zimmet JM, Hare JM: Nitroso-redox interactions in the cardiovascular system. Circulation 114:1531-1544, 2006.
14. Sun J, Murphy E: Protein S-nitrosylation and cardioprotection. Circ Res 106: 285-296, 2010.
15. Nagasaka Y, Buys ES, Spagnolli E, Steinbicker AU, Hayton SR, Rauwerdink KM, Brouckaert P, Zapol WM, Bloch KD: Soluble guanylate cyclase-alpha1 is required for the cardioprotective effects of inhaled nitric oxide. Am J Physiol Heart Circ Physiol 300:H1477-H1483, 2011.
16. Burley DS, Ferdinandy P, Baxter GF: Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol 152:855-869, 2007.
17. Garcia-Dorado D, Agullo L, Sartorio CL, Ruiz-Meana M: Myocardial protection against reperfusion injury: the cGMP pathway. Thromb Haemost 101: 635-642, 2009.
18. Minamishima S, Kida K, Tokuda K, Wang H, Sips PY, Kosugi S, Mandeville JB, Buys ES, Brouckaert P, Liu PK, et al.: Inhaled nitric oxide improves outcomes after successful cardiopulmonary resuscitation in mice. Circulation 124:1645-1653, 2011.
19. Baker JE, Su J, Fu X, Hsu A, Gross GJ, Tweddell JS, Hogg N: Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels. J Mol Cell Cardiol 43:437-444, 2007.
20. Bryan NS, Calvert JW, Elrod JW, Gundewar S, Ji SY, Lefer DJ: Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA 104:19144-19149, 2007.
21. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, et al.: Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 115: 1232-1240, 2005.
22. Gonzalez FM, Shiva S, Vincent PS, Ringwood LA, Hsu LY, Hon YY, Aletras AH, Cannon RO 3rd, Gladwin MT, Arai AE: Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction. Circulation 117:2986-2994, 2008.
23. Lu P, Liu F, Yao Z, Wang CY, Chen DD, Tian Y, Zhang JH, Wu YH: Nitritederived nitric oxide by xanthine oxidoreductase protects the liver against ischemia-reperfusion injury. Hepatobiliary Pancreat Dis Int 4:350-355, 2005.
24. Tripatara P, Patel NS, Webb A, Rathod K, Lecomte FM, Mazzon E, Cuzzocrea S, Yaqoob MM, Ahluwalia A, Thiemermann C: Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase. J Am Soc Nephrol 18:570-580, 2007.
25. Webb A, Bond R, McLean P, Uppal R, Benjamin N, Ahluwalia A: Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemiareperfusion damage. Proc Natl Acad Sci USA 101:13683-13688, 2004.
26. Prime TA, Blaikie FH, Evans C, Nadtochiy SM, James AM, Dahm CC, Vitturi DA, Patel RP, Hiley CR, Abakumova I, et al.: A mitochondriatargeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury. Proc Natl Acad Sci USA 106: 10764-10769, 2009.
27. Nadtochiy SM, Burwell LS, Ingraham CA, Spencer CM, Friedman AE, Pinkert CA, Brookes PS: In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine. J Mol Cell Cardiol 46:960-968, 2009.
28. Garcia-Criado FJ, Rodriguez-Barca P, Garcia-Cenador MB, Rivas-Elena JV, Grande MT, Lopez-Marcos JF, Mourelle M, Lopez-Novoa JM: Protective effect of new nitrosothiols on the early inflammatory response to kidney ischemia/reperfusion and transplantation in rats. J Interferon Cytokine Res 29:441-450, 2009.
29. Johnson TA, Stasko NA, Matthews JL, Cascio WE, Holmuhamedov EL, Johnson CB, Schoenfisch MH: Reduced ischemia/reperfusion injury via glutathione- initiated nitric oxide-releasing dendrimers. Nitric Oxide 22: 30-36, 2010.
30. Hogg N, Broniowska KA, Novalija J, Kettenhofen NJ, Novalija E: Role of S-nitrosothiol transport in the cardioprotective effects of S-nitrosocysteine in rat hearts. Free Radic Biol Med 43:1086-1094, 2007.
31. Liu B, Tewari AK, Zhang L, Green-Church KB, Zweier JL, Chen YR, He G: Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: mitochondria as the major target. Biochim Biophys Acta 1794:476-485, 2009.
32. Souza JM, Peluffo G, Radi R: Protein tyrosine nitrationVfunctional alteration or just a biomarker? Free Radic Biol Med 45:357-366, 2008.
33. Willmot M, Gray L, Gibson C, Murphy S, Bath PM: A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide 12:141-149, 2005.
34. Lamontagne F, Meade M, Ondiveeran HK, Lesur O, Fox-Robichaud AE: Nitric oxide donors in sepsis: a systematic review of clinical and in vivo preclinical data. Shock 30:653-659, 2008.
35. Higgins JPT, Green S: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. Available at: http://www.cochrane-handbook.org. Accessed January 4, 2012.
36. Arom KV, Angaran DM, Lindsay WG, Northrup WF, Nicoloff DM: Effect of sodium nitroprusside during the payback period of cardiopulmonary bypass on the incidence of postoperative arrhythmias. Ann Thorac Surg 34:307-312, 1982.
37. Kaya K, Oguz M, Akar AR, Durdu S, Aslan A, Erturk S, Tasoz R, Ozyurda U: The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Eur J Cardiothorac Surg 31:290-297, 2007.
38. Lang JD Jr, Teng X, Chumley P, Crawford JH, Isbell TS, Chacko BK, Liu Y, Jhala N, Crowe DR, Smith AB, et al.: Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 117:2583-2591, 2007.
39. Hildebrandt P, Torp-Pedersen C, Joen T, Iversen E, Jensen G, Jeppesen D, Melchior T, Schytten HJ, Ringsdal V, Jensen J, et al.: Reduced infarct size in nonreperfused myocardial infarction by combined infusion of isosorbide dinitrate and streptokinase. Am Heart J 124:1139-1144, 1992.
40. Meade MO, Granton JT, Matte-Martyn A, McRae K, Weaver B, Cripps P, Keshavjee SH: A randomized trial of inhaled nitric oxide to prevent ischemiareperfusion injury after lung transplantation. Am J Respir Crit Care Med 167:1483-1489, 2003.
41. Amit G, Cafri C, Yaroslavtsev S, Fuchs S, Paltiel O, Abu-Ful A, Weinstein JM, Wolak A, Ilia R, Zahger D: Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial. Am Heart J 2006;152:887.e9Ye14.
42. Honda HM, Korge P, Weiss JN: Mitochondria and ischemia/reperfusion injury. Ann N Y Acad Sci 1047:248-258, 2005.
43. Rouslin W: Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am J Physiol 244:H743-H748, 1983.
44. Sack MN: Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc Res 72:210-219, 2006.
45. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS: Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 6:150-166, 2005.
46. Martinez-Ruiz A, Lamas S: S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc Res 62:43-52, 2004.
47. Levine AB, Punihaole D, Levine TB: Characterization of the role of nitric oxide and its clinical applications. Cardiology 122:55-68, 2012.
48. Cui S, Shibamoto T, Ruan Z, Takano H, Liu W, Kurata Y: Oxygen consumption, assessed with the oxygen absorption spectrophotometer, decreases independently of venoconstriction during hepatic anaphylaxis in perfused rat liver. Shock 26:62-68, 2006.
49. Mariano F, Bussolati B, Migliori M, Russo S, Triolo G, Camussi G: Plateletactivating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production. Shock 19:339-344, 2003.
50. Godoy LC, Moretti AI, Jurado MC, Oxer D, Janiszewski M, Ckless K, Velasco IT, Laurindo FR, Souza HP: Loss of CD40 endogenous S-nitrosylation during inflammatory response in endotoxemic mice and patients with sepsis. Shock 33:626-633, 2010.
51. Gundersen Y, Corso CO, Leiderer R, Dorger M, Lilleaasen P, Aasen AO, Messmer K: The nitric oxide donor sodium nitroprusside protects against hepatic microcirculatory dysfunction in early endotoxaemia. Intensive Care Med 24:1257-1263, 1998.
52. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF: Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 360:1395-1396, 2002.
53. Kubli S, Boegli Y, Ave AD, Liaudet L, Revelly JP, Golay S, Broccard A, Waeber B, Schaller MD, Feihl F: Endothelium-dependent vasodilation in the skin microcirculation of patients with septic shock. Shock 19:274-280, 2003.
54. Donadello K, Favory R, Salgado-Ribeiro D, Vincent JL, Gottin L, Scolletta S, Creteur J, De Backer D, Taccone FS: Sublingual and muscular microcirculatory alterations after cardiac arrest: a pilot study. Resuscitation 82:690-695, 2011.
55. Stowe DF, Camara AK: Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal 11:1373-1414, 2009.
56. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437, 1996.
57. Flogel U, Decking UK, Godecke A, Schrader J: Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice. J Mol Cell Cardiol 31:827-836, 1999.
58. Woolfson RG, Patel VC, Neild GH, Yellon DM: Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 91:1545-1551, 1995.
59. Yang M, Camara AK, Wakim BT, Zhou Y, Gadicherla AK, Kwok WM, Stowe DF: Tyrosine nitration of voltage dependent anion channels in cardiac ischemia-reperfusion: reduction by peroxynitrite scavenging. Biochim Biophys Acta 2012;1817:2049-2059.
60. Dezfulian C, Shiva S, Alekseyenko A, Pendyal A, Beiser DG, Munasinghe JP, Anderson SA, Chesley CF, Vanden Hoek TL, Gladwin MT: Nitrite therapy after cardiac arrest reduces reactive oxygen species generation, improves cardiac and neurological function, and enhances survival via reversible inhibition of mitochondrial complex I. Circulation 120:897-905, 2009.
61. Yannopoulos D, Matsuura T, Schultz J, Rudser K, Halperin HR, Lurie KG: Sodium nitroprusside enhanced cardiopulmonary resuscitation improves survival with good neurological function in a porcine model of prolonged cardiac arrest. Crit Care Med 39:1269-1274, 2011.
62. Li H, Cui H, Liu X, Zweier JL: Xanthine oxidase catalyzes anaerobic transformation of organic nitrates to nitric oxide and nitrosothiols: characterization of this mechanism and the link between organic nitrate and guanylyl cyclase activation. J Biol Chem 280:16594-16600, 2005.
63. Chen Z, Zhang J, Stamler JS: Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA 99:8306-8311, 2002.
64. Kowaluk EA, Seth P, Fung HL: Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther 262:916-922, 1992.
65. Butler AR, Megson IL: Non-heme iron nitrosyls in biology. Chem Rev 102:1155-1166, 2002.
66. Grossi L, D'Angelo S: Sodium nitroprusside: mechanism of NO release mediated by sulfhydryl-containing molecules. J Med Chem 48:2622-2626, 2005.
67. Cannon RO 3rd, Schechter AN, Panza JA, Ognibene FP, Pease-Fye ME, Waclawiw MA, Shelhamer JH, Gladwin MT: Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest 108:279-287, 2001.
68. Fox-Robichaud A, Payne D, Hasan SU, Ostrovsky L, Fairhead T, Reinhardt P, Kubes P: Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 101:2497-2505, 1998.
69. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, et al.: Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9:1498-1505, 2003.
70. Huang KT, Keszler A, Patel N, Patel RP, Gladwin MT, Kim-Shapiro DB, Hogg N: The reaction between nitrite and deoxyhemoglobin. Reassessment of reaction kinetics and stoichiometry. J Biol Chem 280:31126-31131, 2005.
71. Huang Z, Shiva S, Kim-Shapiro DB, Patel RP, Ringwood LA, Irby CE, Huang KT, Ho C, Hogg N, Schechter AN, et al.: Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest 115:2099-2107, 2005.
72. Shiva S, Huang Z, Grubina R, Sun J, Ringwood LA, MacArthur PH, Xu X, Murphy E, Darley-Usmar VM, Gladwin MT: Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res 100:654-661, 2007.
73. Millar TM, Stevens CR, Benjamin N, Eisenthal R, Harrison R, Blake DR: Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett 427:225-228, 1998.
74. Gautier C, van Faassen E, Mikula I, Martasek P, Slama-Schwok A: Endothelial nitric oxide synthase reduces nitrite anions to NO under anoxia. Biochem Biophys Res Commun 341:816-821, 2006.
75. Li H, Samouilov A, Liu X, Zweier JL: Characterization of the magnitude and kinetics of xanthine oxidaseYcatalyzed nitrate reduction: evaluation of its role in nitrite and nitric oxide generation in anoxic tissues. Biochemistry 42:1150-1159, 2003.
76. Freyholdt T, Massoudy P, Zahler S, Henze R, Barankay A, Becker BF, Meisner H: Beneficial effect of sodium nitroprusside after coronary artery bypass surgery: pump function correlates inversely with cardiac release of proinflammatory cytokines. J Cardiovasc Pharmacol 42:372-378, 2003.
77. Gianetti J, Del Sarto P, Bevilacqua S, Vassalle C, De Filippis R, Kacila M, Farneti PA, Clerico A, Glauber M, Biagini A: Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg 127:44-50, 2004.
78. Kalweit GA, Schipke JD, Godehardt E, Gams E: Changes in coronary vessel resistance during postischemic reperfusion and effectiveness of nitroglycerin. J Thorac Cardiovasc Surg 122:1011-1018, 2001.
79. Massoudy P, Zahler S, Freyholdt T, Henze R, Barankay A, Becker BF, Braun SL, Meisner H: Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatory substances. J Thorac Cardiovasc Surg 119:566-574, 2000.
80. Massoudy P, Hartl H, Zahler S, Braun S, Barankay A, Becker BF, Meisner H: Plasma lactate concentration in post-ischemic reperfusion of human hearts under treatment with sodium nitroprusside (German). Anasthesiol Intensivmed Notfallmed Schmerzther 34:243-245, 1999.
81. Massoudy P, Zahler S, Barankay A, Becker BF, Richter JA, Meisner H: Sodium nitroprusside during coronary artery bypass grafting: evidence for an antiinflammatory action. Ann Thorac Surg 67:1059-1064, 1999.
82. Yavuz T, Altuntas I, Odabasi D, Delibas N, Ocal A, Ibrisim E, Kutsal A: Beneficial effect of the addition of nitroglycerin to the cardioplegic solution on lipid peroxidation during coronary artery bypass surgery. Int Heart J 46: 45-55, 2005.
83. Zhang WX, Gong GF, Chen SX: Protective effects of low dose nitric oxide inhalation on lung ischemia/reperfusion injury during cardiopulmonary bypass surgery (Chinese). Hunan Yi Ke Da Xue Xue Bao 25:483-486, 2000.
84. Botha P, Jeyakanthan M, Rao JN, Fisher AJ, Prabhu M, Dark JH, Clark SC: Inhaled nitric oxide for modulation of ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant 26:1199-1205, 2007.
85. Cornfield DN, Milla CE, Haddad IY, Barbato JE, Park SJ: Safety of inhaled nitric oxide after lung transplantation. J Heart Lung Transplant 22:903-907, 2003.
86. Moreno I, Vicente R, Mir A, Leon I, Ramos F, Vicente JL, Barbera M: Effects of inhaled nitric oxide on primary graft dysfunction in lung transplantation. Transplant Proc 41:2210-2212, 2009.
87. Perrin G, Roch A, Michelet P, Reynaud-Gaubert M, Thomas P, Doddoli C, Auffray JP: Inhaled nitric oxide does not prevent pulmonary edema after lung transplantation measured by lung water content: a randomized clinical study. Chest 129:1024-1030, 2006.
88. Shinozaki N, Ichinose H, Yahikozawa K, Shimada H, Hoshino K: Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction. Int Heart J 48:423-433, 2007.
89. Jugdutt BI, Schwarz-Michorowski BL, Tymchak WJ, Burton JR: Prompt improvement of left ventricular function and preservation of topography with combined reperfusion and intravenous nitroglycerin in acute myocardial infarction. Cardiology 88:170-179, 1997.
90. Morris JL, Zaman AG, Smyllie JH, Cowan JC: Nitrates in myocardial infarction: influence on infarct size, reperfusion, and ventricular remodelling. Br Heart J 73:310-319, 1995.
91. Ohlin H, Pavlidis N, Ohlin AK: Effect of intravenous nitroglycerin on lipid peroxidation after thrombolytic therapy for acute myocardial infarction. Am J Cardiol 82:1463-1467, 1998.
92. Sun LD, Tang YL, Xi WB, Zhang N, Zhang YZ: Study on the reperfusion rate of acute myocardial infarction affected by inspiring nitric oxide and resolving thrombus intravenously before admission (Chinese). Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16:169-171, 2004.
93. Okorie M, Akram F, Loukogeorgakis S, Webb A, Deanfield J, Benjamin N, Hobbs A, MacAllister R, Ahluwalia A: Oral inorganic nitrate protects against endothelial ischaemia-reperfusion injury in humans. Basic Clin Pharmacol Toxicol 105(Suppl 1):26, 2009.
94. Mathru M, Huda R, Solanki DR, Hays S, Lang JD: Inhaled nitric oxide attenuates reperfusion inflammatory responses in humans. Anesthesiology 106:275-282, 2007.
95. Dragoni S, Gori T, Lisi M, Di Stolfo G, Pautz A, Kleinert H, Parker JD: Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. Arterioscler Thromb Vasc Biol 27:1955-1959, 2007.